SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

JB Chemicals acquires portfolio of brands from Dr Reddy’s

22 Jul 2022 Evaluate

JB Chemicals & Pharmaceuticals has completed the acquisition of portfolio of brands from Dr Reddy’s Laboratories. This acquisition was partly funded from internal accruals and partly through long-term debt. Earlier, the company’s board had approved a proposal to acquire four paediatric brands from Dr Reddy's Laboratories for about Rs 98 crore.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

2192.30 -3.65 (-0.17%)
18-Jun-2026 11:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.80
Dr. Reddys Lab 1267.20
Cipla 1356.00
Zydus Lifesciences 1074.35
Lupin 2292.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: